Alteration of the lipid and apolipoprotein contents of lipoprotein (a) in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 11, Issue 5, 1996, Pages 825-829

  Hugue, V ^a   Kandoussi, M ^a   Parra, H J ^a   Dracon, M ^a   Fruchart, J C ^a   Tacquet, A ^a   Cachera, C ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

apo (a) phenotype; Haemodialysis; Immunoaffinity; Lp(a) apolipoproteins; Lp(a) lipids

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; LIPOPROTEIN A; MONOCLONAL ANTIBODY; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; PRIORITY JOURNAL;

EID: 0029873299     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027406     Document Type: Article

References (28)

1. Rostand SG, Brunzell JD, Cannon RO et al. Cardiovascular complications in renal failure. J Am Soc Nephrol 1991; 2: 1053-1062
2. Attman PO, Samuelsson O, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 1993; 21; 573-591
3. Brunzell JD, Austin MA. Plasma triglyceride levels and coronary disease. N Engl J Med 1989; 320: 1273-1275
4. Barbagallo CM, Averna MR, Scafidi V et al. Increased lipoprotein (a) levels in subjects with chronic renal failure on hemodialysis. Nephron 1992; 62: 471-472
5. Webb AT, Reaveley DA, O'Donnell M et al. Lipoprotein(a) in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993; 8: 609-613
6. Fless GM, Zummallen ME, Scanu AM. Physicochemical properties of apolipoprotein (a) and lipoprotein (a-) derived from the dissociation of human plasma lipoprotein (a). J Biol Chem 1986; 261: 8712-8718
7. Utermann G, Menzel HJ, Kraft HG et al. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80: 458-465
8. Sigurdson G, Baldurstdottir A, Sigvaldson H et al. Predictive value of apolipoproteins in a propective survey of coronary artery disease in men. Am J Cardiol 1992; 69: 1251-1254
9. Mbewu A, Durrington PN. Lipoprotein(a): structure, properties and possible involment in thrombogenesis and atherogenesis. Atherosclerosis 1990; 85: 1-14
10. Cressman MD, Heyka RJ, Paganini EP et al. Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992; 86: 475-482
11. Dieplinger H, Lackner C, Kronenberg F. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993; 91: 397-401
12. Bard JM, Candeher L. Agnani G et al. Isolation and characterization of human Lp-B lipoprotein containing apolipoprotein B as the sole apolipoprotein. Biochim Biophys Acta 1991; 1082: 170-176
13. Fless GM, Snyder ML. Scanu AM. Enzyme-linked immunoassay for Lp(a). J Lipid Res 1989; 30: 651-662
14. Sandkamp M, Funke H, Schulte H, Kohler E, Assman G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990; 36: 20-23
15. Hearn JA, Donohue BC, Ba'albaki H et al. Usefulness of serum Lp(a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1992; 69: 736-739
16. Cambillau M, Simon A, Amar J et al. Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extra coronary sites in hypercholesterolemic men. Arterioscler Thromb 1992; 12: 1346-1352
17. Castro GR, Fielding CJ. Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (LpE). J Lipid Res 1984; 25: 58-67
18. Yang WS, Kim SB, Min WK et al. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients. Nephrol Dial Transplant 1995; 10: 1668-1671
19. Attman PO, Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia - Relation to renal function and dialysis. Nephron 1991; 57: 401-410
20. Senti M, Romero R, Pedro-Botet J et al. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 1992; 41: 1394-1399
21. Albers JJ, Cheung MC, Floren CH. Methodological considerations in apolipoprotein immunoassay. In: Gotto AM, Smith LC, Allen B, ed. Atherosclerosis V. Springer-Verlag, New York, 1980: 811-815
22. Bard JM, Delattre-Lestavel S. Clavey V et al. Isolation and characterization of two sub-species of Lp(a), one containing apo E and one free of apo E. Biochim Biophys Acta 1992; 1127: 124-130
23. Ron D, Oren I, Aviram M et al. Accumulation of lipoprotein remnants in patients with chronic renal failure. Atherosclerosis 1983; 46: 67-75
24. Chan MK, Persaud J, Varghese Z, Moorhead JF. Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients. Kidney Int 1984; 25: 812-818
25. Goldberg AP, Sherrard DJ, Brunzell JD. Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism. J Clin Endocrinol Metab 1978; 47: 1173-1182
26. Rader DJ, Cain W, Ikewaki K et al. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein (a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate J Clin Invest 1994; 93: 2758-2763
27. Aviram M, Lund-Katz S, Phillips MC et al. The influence of the triglycerides content of low density lipoprotein on the interaction of the apolipoprotein B-100 with cells. J Biol Chem 1988; 263: 16842-16848
28. Agnani G, Bard JM, Candelier L et al. Interaction of Lp B, Lp B : E, Lp B : C III and Lp B : CIII : E lipoproteins with the low density lipoproteins receptor of HeLa cells. Arierioscler Thromb 1991, 11: 1021-1029